Communications Committee: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
m →Scope |
||
| Line 4: | Line 4: | ||
* [https://docs.google.com/spreadsheets/d/1w-kGTqObvK-mVtjja1d-Yxs9fwNZnAZmdwUklB2zvBc/edit#gid=1807281004 Roster] | * [https://docs.google.com/spreadsheets/d/1w-kGTqObvK-mVtjja1d-Yxs9fwNZnAZmdwUklB2zvBc/edit#gid=1807281004 Roster] | ||
==Communications Committee Mission Statement== | |||
QIBA Communications will educate and publicize the impact of image quantification on therapeutic and drug clinical trials and patient disease staging and follow-up. | |||
Oversee educational component | |||
==Scope== | ==Scope== | ||
| Line 9: | Line 14: | ||
:* tbd | :* tbd | ||
:* tbd | :* tbd | ||
==Meetings/Call Summaries== | ==Meetings/Call Summaries== | ||
Revision as of 02:06, 30 January 2021
- Chairs: Anne M. Smith, PhD; Majid Chalian, MD
- RSNA Staff Support: Julie Lisiecki
Communications Committee Mission Statement
QIBA Communications will educate and publicize the impact of image quantification on therapeutic and drug clinical trials and patient disease staging and follow-up. Oversee educational component
Scope
The Communications Committee supports QIBA Biomarker Committees by providing visibility to QIBA efforts.
- tbd
- tbd
Meetings/Call Summaries
Monthly Tcons (Contact Julie for details)
Approved call summaries: